VolitionRx Limited to Webcast Live at Life Sciences Investor Forum March 25th

Rhea-AI Summary

VolitionRx Limited (NYSE AMERICAN: VNRX) will present live at LifeSciencesInvestorForum.com on March 25, 2021, at 11:00 AM ET. The company's EVP of Investor Relations, Scott Powell, will lead the interactive event, allowing investors to ask questions in real-time. VolitionRx specializes in developing cost-effective blood tests for diagnosing various cancers and diseases in humans and animals. Interested participants are encouraged to pre-register for the event.

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

AUSTIN, Texas, March 22, 2021 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today announced that Scott Powell, EVP of Investor Relations and Chief Financial Officer of Volition America Inc., will present live at LifeSciencesInvestorForum.com on March 25^th.

DATE: Thursday, March 25^th
TIME: 11:00 AM ET
LINK: https://bit.ly/3qVRFyI

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.lifesciencesinvestorforum.com.

About VolitionRx Limited

Volition is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics^TM, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.

Volition's research and development activities are centered in Belgium, with a small laboratory in California and additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market.

For more information about Volition, visit Volition's website volition.com or connect with us via:
Twitter: https://twitter.com/volitionrx
LinkedIn: https://www.linkedin.com/company/volitionrx
Facebook: https://www.facebook.com/VolitionRx/

The contents found at Volition's website address, Twitter, LinkedIn, Facebook, and YouTube are not incorporated by reference into this document and should not be considered part of this document. The addresses for Volition's website, Twitter, LinkedIn, Facebook, and YouTube are included in this document as inactive textual references only.

About Life Sciences Investor Forum

Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

FAQ

When will VolitionRx present at Life Sciences Investor Forum?

VolitionRx will present live at Life Sciences Investor Forum on March 25, 2021, at 11:00 AM ET.

Who is presenting for VolitionRx at the investor forum?

Scott Powell, EVP of Investor Relations and Chief Financial Officer of Volition America Inc., will present.

What is the purpose of the Life Sciences Investor Forum presentation?

The presentation aims to provide an interactive platform for investors to engage with VolitionRx and ask questions.

How can I attend the VolitionRx presentation at the investor forum?

Investors can attend the presentation by registering on LifeSciencesInvestorForum.com.

Is there a recording available for the VolitionRx presentation?

Yes, an archived webcast of the presentation will be available after the event for those unable to attend live.